Related Experiment Videos
Current medical management of diabetic foot infections
Mark A Kosinski1, Benjamin A Lipsky
1Division of Medical Sciences, New York College of Podiatric Medicine, 53 East 124th Street, New York, NY 10035, USA. mkosins@nycpm.edu
Abstract:
Foot infections are a serious complication of diabetes associated with substantial morbidity and occasional mortality. Antibiotic therapy for mild infections in patients who have not recently received antibiotic therapy can often be directed at just staphylococci and streptococci. Empiric therapy for infections that are chronic, moderate or severe, or that occur in patients who have failed previous antibiotic treatment, should usually be more broad spectrum. Bone infection also complicates a substantial percentage of diabetic foot wounds and increases the likelihood of treatment failure, requiring lower extremity amputation. An increasing body of evidence supports the effectiveness of nonsurgical treatment of diabetic foot osteomyelitis in selected patients, although the optimal choice of agent, route of administration and duration of therapy have yet to be defined. This article examines the potential role of standard and newer antibiotics that may be appropriate for treating diabetic foot infections, including ertapenem, vancomycin, moxifloxacin, daptomycin, telavancin and tigecycline, as well as several investigational agents, such as dalbavancin, ceftobiprole and nemonoxacin.
Insights
Diabetic foot infections require tailored antibiotic strategies. Newer and standard antibiotics are evaluated for treating these complex infections, including bone infections, to improve outcomes and prevent amputations.
Area of Science:
- Infectious Diseases
- Diabetology
- Pharmacology
Background:
- Diabetic foot infections are a severe complication with significant morbidity and mortality.
- Mild infections may be treated with narrow-spectrum antibiotics targeting staphylococci and streptococci.
- Chronic, severe, or treatment-resistant infections necessitate broad-spectrum antibiotic coverage.
Purpose of the Study:
- To review standard and novel antibiotic agents for diabetic foot infections.
- To discuss antibiotics for diabetic foot osteomyelitis, a common complication.
- To highlight emerging agents for complex diabetic foot infections.
Main Methods:
- Literature review of antibiotic therapies for diabetic foot infections.
- Analysis of current evidence on antibiotic selection, route, and duration.
- Examination of established and investigational antibiotic agents.
Main Results:
- Antibiotic choice depends on infection severity, chronicity, and prior treatment.
- Diabetic foot osteomyelitis often requires extended or specialized antibiotic therapy.
- Several standard (ertapenem, vancomycin) and newer agents (dalbavancin, ceftobiprole) show promise.
Conclusions:
- Optimizing antibiotic therapy is crucial for managing diabetic foot infections.
- Nonsurgical treatment of diabetic foot osteomyelitis is increasingly viable.
- Further research is needed to define optimal antibiotic regimens for diabetic foot infections.
Related Concept Videos
Diabetic Foot Ulcer
Peripheral Artery Disease IV: Nursing Management
Endocarditis III: Medical Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Endocarditis IV: Nursing Management
Urinary Tract Infection IV: Nursing Management